Uncategorized
BioTime Presents Retinal Restoration Data at ARVO
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that a poster related to the Company’s retinal restoration technology was presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Baltimore, Maryland on May 11, 2017. BioTime scientists have grown full-thickness, 3-D retinal tissue using the Company’s proprie